Pfizer, marking fast research pace, starts key trial of RSV vaccine
A vaccine against RSV has proven elusive despite decades of attempts. Pfizer is moving at a surprisingly quick pace to catch up to rivals led by GlaxoSmithKline, who ...
Continue Reading →
